← Eichor
Study identifier: NCT05269628 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Condition: Multiple Sclerosis · Sleep · Pain  ·  Sponsor: Tiffany J. Braley, MD, MS

PhasePhase 2
Planned participants166
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The purpose of this research study is to compare the effects of cannabidiol (CBD), tetrahydrocannabinol (THC), or both, on sleep and pain in persons with multiple sclerosis (MS). Little is known about how CBD and/or THC may help sleep, reduce pain, or perhaps even treat pain through better sleep.

This description comes directly from the study's public registry record.

Talk to the study team

David Johnson  ·  734-615-9650  ·  johnsodj@umich.edu

Pickup Kristen  ·  734-764-4072  ·  knpicku@med.umich.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MichiganAnn Arbor, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05269628